The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Classification and Pathology of Lung Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Liquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Johnson, D. H., Fehrenbacher, L., Novotny, W. F., Herbst, R. S., Nemunaitis, J. J., Jablons, D. M., Langer, C. J., DeVore, R. F., Gaudreault, J., Damico, L. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.022 · Cited by 1,937
WHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
New driver mutations in non-small-cell lung cancer
Pao, W., & Girard, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70087-5 · Cited by 1,128
Klimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
The Next-Generation Sequencing Revolution and Its Impact on Genomics
Koboldt, D. C., Steinberg, K. M., Larson, D. E., Wilson, R. K., & Mardis, E. R. (2013) · Cell · doi:10.1016/j.cell.2013.09.006 · Cited by 1,037
Yoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Azzoli, C. G., Baker, S., Temin, S., Pao, W., Aliff, T., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5622 · Cited by 915
Travis, W. D., Linnoila, R. I., Tsokos, M. G., Hitchcock, C. L., Cutler, G. B., Nieman, L., Chrousos, G., Pass, H., & Doppman, J. (1991) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199106000-00003 · Cited by 880
Masters, G. A., Temin, S., Azzoli, C. G., Giaccone, G., Baker, S., Brahmer, J. R., Ellis, P. M., Gajra, A., Rackear, N., Schiller, J. H., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.1342 · Cited by 850
New driver mutations in non-small-cell lung cancer
Tanoue, L. T. (2012) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2012.01.036 · Cited by 831
Travis, W. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00061-3 · Cited by 655
Russell, P. A., Wainer, Z., Wright, G. M., Daniels, M., Conron, M., & Williams, R. A. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318221f701 · Cited by 624
Travis, W. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.005 · Cited by 520
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.001 · Cited by 462
Neuroendocrine Tumors of the Lung: An Update
Rekhtman, N. (2010) · Archives of Pathology and Laboratory Medicine · doi:10.5858/2009-0583-rar.1 · Cited by 445
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0720-oa · Cited by 426
Mino-Kenudson, M., Chirieac, L. R., Law, K., Hornick, J. L., Lindeman, N., Mark, E. J., Cohen, D. W., Johnson, B. E., Jänne, P. A., Iafrate, A. J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2845 · Cited by 423
Fink, G., Krelbaum, T., Yellin, A., Bendayan, D., Saute, M., Glazer, M., & Kramer, M. R. (2001) · Chest · doi:10.1378/chest.119.6.1647 · Cited by 415
Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine
Tucker, T., Marra, M., & Friedman, J. M. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.022 · Cited by 386
Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
Gainor, J. F., & Shaw, A. T. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0095 · Cited by 342
Rekhtman, N., Ang, D. C., Sima, C. S., Travis, W. D., & Moreira, A. L. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.92 · Cited by 339
Sica, G., Yoshizawa, A., Sima, C. S., Azzoli, C. G., Downey, R. J., Rusch, V. W., Travis, W. D., & Moreira, A. L. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181e4ee32 · Cited by 325
Nitadori, J.-I., Bograd, A. J., Kadota, K., Sima, C. S., Rizk, N. P., Morales, E. A., Rusch, V. W., Travis, W. D., & Adusumilli, P. S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt166 · Cited by 323
Mukhopadhyay, S., & Katzenstein, A.-L. A. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182036d05 · Cited by 314
Stewart, E., Tan, S. Z., Liu, G., & Tsao, M. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2014.11.06 · Cited by 305
Ellison, G., Zhu, G., Moulis, A., Dearden, S., Speake, G., & McCormack, R. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201194 · Cited by 301
US lung cancer trends by histologic type
Lewis, D. R., Check, D. P., Caporaso, N. E., Travis, W. D., & Devesa, S. S. (2014) · Cancer · doi:10.1002/cncr.28749 · Cited by 264
Tsuta, K., Kawago, M., Inoue, E., Yoshida, A., Takahashi, F., Sakurai, H., Watanabe, S.-I., Takeuchi, M., Furuta, K., Asamura, H., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.06.012 · Cited by 240
Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
Linardou, H., Dahabreh, I. J., Bafaloukos, D., Kosmidis, P., & Murray, S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.62 · Cited by 234
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
Loo, P. S., Thomas, S. C., Nicolson, M. C., Fyfe, M. N., & Kerr, K. M. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d40fac · Cited by 226
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
Rindi, G., Klersy, C., Inzani, F., Fellegara, G., Ampollini, L., Ardizzoni, A., Campanini, N., Carbognani, P., De Pas, T. M., Galetta, D., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0246 · Cited by 217
Couraud, S., Vaca-Paniagua, F., Villar, S., Oliver, J., Schuster, T., Blanché, H., Girard, N., Trédaniel, J., Guilleminault, L., Gervais, R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3063 · Cited by 215
Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
Pines, G., Köstler, W. J., & Yarden, Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.019 · Cited by 187
ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas
Sholl, L. M., Sun, H., Butaney, M., Zhang, C., Lee, C., Jänne, P. A., & Rodig, S. J. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182960fa7 · Cited by 187
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K., Yatabe, Y., Ishikawa, Y., Wistuba, I., Flieder, D. B., Franklin, W., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0264-ra · Cited by 179
Ilié, M., Hofman, V., Long-Mira, É., Bordone, O., Selva, É., Washetine, K., Marquette, C., & Hofman, V. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.08.11 · Cited by 175
Large cell neuroendocrine carcinoma: An aggressive form of non-small cell lung cancer
Battafarano, R. J., Fernandez, F. G., Ritter, J., Meyers, B. F., Guthrie, T. J., Cooper, J. D., & Patterson, G. A. (2005) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.02.064 · Cited by 161
Yanagawa, N., Shiono, S., Abiko, M., Ogata, S., Satô, T., & Tamura, G. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318287c3eb · Cited by 160
Kadota, K., Yeh, Y., Sima, C. S., Rusch, V. W., Moreira, A. L., Adusumilli, P. S., & Travis, W. D. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.188 · Cited by 154
Sarcomatoid Neoplasms of the Lung and Pleura
Travis, W. D. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0086-rar.1 · Cited by 146
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Martin, L. W., Correa, A. M., Ordóǹez, N. G., Roth, J. A., Swisher, S. G., Vaporciyan, A. A., Walsh, G. L., & Rice, D. C. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.03.099 · Cited by 146
Expression of Thyroid Transcription Factor-1 in Normal and Neoplastic Lung Tissues
Nakamura, N., Miyagi, E., Murata, S., et al. (2002) · Modern Pathology · doi:10.1097/01.mp.0000028572.44247.cf · Cited by 144
Immunohistochemistry in Undifferentiated Neoplasm/Tumor of Uncertain Origin
Lin, F., & Liu, H. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0061-ra · Cited by 144
Pelosi, G., Fabbri, A., Bianchi, F., Maisonneuve, P., Rossi, G., Barbareschi, M., Graziano, P., Cavazza, A., Rekhtman, N., Pastorino, U., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823815d3 · Cited by 143
Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
Rothschild, S. I. (2015) · Cancers · doi:10.3390/cancers7020816 · Cited by 125
A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas
Nonaka, D. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182498f2b · Cited by 116
Rekhtman, N., Tafe, L. J., Chaft, J. E., Wang, L., Arcila, M. E., Colanta, A., Moreira, A. L., Zakowski, M. F., Travis, W. D., Sima, C. S., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.195 · Cited by 113
Adenosquamous Carcinoma of the Lung
Tochigi, N., Đačić, S., Nikiforova, M. N., Cieply, K. M., & Yousem, S. A. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp08iqzaogylfl · Cited by 97
Prognostic and predictive biomarkers in lung cancer. A review
Thunnissen, E., der Oord, K. V., & den Bakker, M. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1535-4 · Cited by 92
Woo, T., Okudela, K., Mitsui, H., Tajiri, M., Yamamoto, T., Rino, Y., Ohashi, K., & Masuda, M. (2012) · Pathology International · doi:10.1111/pin.12016 · Cited by 91
Kadota, K., Nitadori, J., Rekhtman, N., Jones, D. R., Adusumilli, P. S., & Travis, W. D. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000439 · Cited by 76
Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond.
Khoo, C., Rogers, T.-M., FELLOWES, A. P., Bell, A. H., & Fox, S. B. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2015.01.10 · Cited by 75
Filosso, P. L., Rena, O., Guerrera, F., Moreno, P., Sagan, D., Raveglia, F., Brunelli, A., Welter, S., Gust, L., Pompili, C., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu404 · Cited by 71
Large Cell Carcinoma of the Lung: An Endangered Species?
Pardo, J., Martínez-peñuela, A., Sola, J. J., Panizo, Á., Gúrpide, A., Martínez-Peñuela, J. M., & Lozano, M. D. (2009) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31819bfd59 · Cited by 66
Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer
Nie, K., Jia, Y., & Zhang, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2758-3 · Cited by 61
Li, Y., Pan, Y., Wang, R., Sun, Y., Hu, H., Shen, X., Lu, Y., Shen, L., Zhu, X., & Chen, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069016 · Cited by 60
Small cell lung cancer: new clinical recommendations and current status of biomarker assessment
Planchard, D., & Pechoux, C. L. (2011) · European Journal of Cancer · doi:10.1016/s0959-8049(11)70173-3 · Cited by 60
Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application
Maione, P., Sacco, P. C., Sgambato, A., Casaluce, F., Rossi, A., & Gridelli, C. (2015) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834015595048 · Cited by 59
Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity
Brambilla, C., Laffaire, J., Lantuéjoul, S., Moro‐Sibilot, D., Nagy-Mignotte, H., Arbib, F., Toffart, A., Petel, F., Hainaut, P. L., Rousseaux, S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0459 · Cited by 59
Prognostic and predictive value of MET deregulation in non-small cell lung cancer.
Finocchiaro, G., Toschi, L., Gianoncelli, L., Baretti, M., & Santoro, A. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.03.43 · Cited by 58
Coco, S., Truini, A., Vanni, I., Bello, M. G. D., Alama, A., Rijavec, E., Genova, C., Barletta, G., Sini, C., Burrafato, G., et al. (2014) · Current Drug Targets · doi:10.2174/1389450116666141210094640 · Cited by 54
Brown, A. F., Sirohi, D., Fukuoka, J., Cagle, P. T., Policarpio‐Nicolas, M. L., Tacha, D., & Jagirdar, J. S. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0635-oa · Cited by 53
Hasanovic, A., Ang, D. C., Moreira, A. L., & Zakowski, M. F. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.04.004 · Cited by 50
Seo, A. N., Park, T.-I., Jin, Y. J., Sun, P.-L., Kim, H., Chang, H. K., & Chung, J.-H. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.12.008 · Cited by 49
Hwang, D. H., Szeto, D. P., Perry, A. S., Bruce, J. L., & Sholl, L. M. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2013-0179-oa · Cited by 48
Molecular testing in lung cancer in the era of precision medicine.
Popper, H., Ryška, A., Tímár, J., & Olszewski, W. T. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2014.10.01 · Cited by 47
The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools
Verma, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7215-0_5 · Cited by 46
Thunnissen, E., Noguchi, M., Aisner, S. C., Beasley, M. B., Brambilla, E. M., Chirieac, L. R., Chung, J.-H., Đačić, S., Geisinger, K. R., Hirsch, F. R., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000264 · Cited by 45
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
Stella, G. M., Scabini, R., Inghilleri, S., Cemmi, F., Corso, S., Pozzi, E., Morbini, P., Valentini, A., Dore, R., Ferrari, S., et al. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1444-y · Cited by 42
Gold, K. A., Wistuba, I. I., & Kim, E. S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2055 · Cited by 37
Sholl, L. M. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000068 · Cited by 37
Utility of small biopsies for diagnosis of lung nodules: doing more with less
Mukhopadhyay, S. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.153 · Cited by 35
Novel agents in development for advanced non-small cell lung cancer
Stinchcombe, T. E. (2014) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834014532510 · Cited by 35
Conde, E., Angulo, B., Izquierdo, E., Paz-Ares, L. G., Belda-Iniesta, C., Hidalgo, M. M., & López‐Ríos, F. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0983-z · Cited by 31
Routine Clinical Mutation Profiling of Non–Small Cell Lung Cancer Using Next-Generation Sequencing
Deeb, K. K., Hohman, C., Risch, N. F., Metzger, D. J., & Starostik, P. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0095-oa · Cited by 31
Anaplastic lymphoma kinase rearrangement in lung Cancer: Its biological and clinical significance
Toyokawa, G., & Seto, T. (2014) · Respiratory Investigation · doi:10.1016/j.resinv.2014.06.005 · Cited by 24
Hayashi, T., Sano, H., Egashira, R., Tabata, K., Tanaka, T., Nakayama, T., Kashima, Y., Hori, T., Nunomura‐Nakamura, S., & Fukuoka, J. (2013) · BioMed Research International · doi:10.1155/2013/157838 · Cited by 20
Current and future molecular diagnostics in non-small-cell lung cancer
Li, C. M., Chu, W. Y., Wong, D. L., Tsang, H. F., Tsui, N. B. Y., Chan, C. M. L., Xue, V. W., Siu, P. M., Yung, B. Y., Chan, L., et al. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1063420 · Cited by 16
Lee, M.-C., Kadota, K., Buitrago, D., Jones, D. R., & Adusumilli, P. S. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2014.09.13 · Cited by 15
Cited by
Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer
Sadeghi, M. M., Salama, M. F., & Hannun, Y. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115527 · Cited by 31
Metadata
- Authors
- Zheng, M.
- Venue
- Surgical Oncology Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 25
- Issue
- 3
- Pages
- 447-468
- ISSN
- 1055-3207 (ISSN-L)
- OpenAlex
- W2416907124
- Cited by
- 398
- References
- 86
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.